Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus

Yen, 2018, Lupus-an unrecognized leading cause of death in young females: a population-based study using nationwide death certificates, 2000–2015, Arthritis Rheum, 70, 1251, 10.1002/art.40512 Parks, 2017, Understanding the role of environmental factors in the development of systemic lupus erythematosus, Best Pract Res Clin Rheumatol, 31, 306, 10.1016/j.berh.2017.09.005 Carter, 2016, The global burden of SLE: prevalence, health disparities and socioeconomic impact, Nat Rev Rheumatol, 12, 605, 10.1038/nrrheum.2016.137 Rees, 2016, The incidence and prevalence of systemic lupus erythematosus in the UK, 1999–2012, Ann Rheum Dis, 75, 136, 10.1136/annrheumdis-2014-206334 Somers, 2014, Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program, Arthritis Rheum, 66, 369, 10.1002/art.38238 Lim, 2014, The incidence and prevalence of systemic lupus erythematosus, 2002–2004: the Georgia Lupus Registry, Arthritis Rheum, 66, 357, 10.1002/art.38239 Izmirly, 2017, The incidence and prevalence of systemic lupus erythematosus in New York county (Manhattan), New York: the Manhattan lupus surveillance program, Arthritis Rheum, 69, 2006, 10.1002/art.40192 Dall'Era, 2017, The incidence and prevalence of systemic lupus erythematosus in san Francisco county, California: the California lupus surveillance Project, Arthritis Rheum, 69, 1996, 10.1002/art.40191 Hermansen, 2016, Incidence of systemic lupus erythematosus and lupus nephritis in Denmark: a nationwide cohort study, J Rheumatol, 43, 1335, 10.3899/jrheum.151221 Arnaud, 2014, Prevalence and incidence of systemic lupus erythematosus in France: a 2010 nation-wide population-based study, Autoimmun Rev, 13, 1082, 10.1016/j.autrev.2014.08.034 Gergianaki, 2017, Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece, Ann Rheum Dis, 76, 1992, 10.1136/annrheumdis-2017-211206 Flower, 2012, Systemic lupus erythematosus in an African Caribbean population: incidence, clinical manifestations, and survival in the Barbados National Lupus Registry, Arthritis Care Res (Hoboken), 64, 1151 Chiu, 2010, Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan, Lupus, 19, 1250, 10.1177/0961203310373780 Lewis, 2017, The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus, Rheumatology (Oxford), 56, i67 Brinks, 2014, Age-specific prevalence of diagnosed systemic lupus erythematosus in Germany 2002 and projection to 2030, Lupus, 23, 1407, 10.1177/0961203314540352 Petri, 2012, Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus, Arthritis Rheum, 64, 2677, 10.1002/art.34473 Ungprasert, 2017, Incidence of systemic lupus erythematosus in a population-based cohort using revised 1997 American College of Rheumatology and the 2012 Systemic Lupus International Collaborating Clinics classification criteria, Lupus, 26, 240, 10.1177/0961203316657434 Ferucci, 2014, Prevalence and incidence of systemic lupus erythematosus in a population-based registry of American Indian and Alaska Native people, 2007–2009, Arthritis Rheum, 66, 2494, 10.1002/art.38720 Housey, 2015, Incidence and prevalence of systemic lupus erythematosus among Arab and chaldean Americans in southeastern Michigan: the Michigan lupus epidemiology and surveillance program, Am J Publ Health, 105, e74, 10.2105/AJPH.2014.302423 Barber, 2017, Socioeconomic consequences of systemic lupus erythematosus, Curr Opin Rheumatol, 29, 480, 10.1097/BOR.0000000000000416 Margery-Muir, 2017, Gender balance in patients with systemic lupus erythematosus, Autoimmun Rev, 16, 258, 10.1016/j.autrev.2017.01.007 Cattalini, 2017, Sex differences in pediatric rheumatology, Clin Rev Allergy Immunol, 10.1007/s12016-017-8642-3 Krasselt, 2017, Sex, symptom severity, and quality of life in rheumatology, Clin Rev Allergy Immunol, 10.1007/s12016-017-8631-6 Rees, 2017, The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies, Rheumatology (Oxford), 56, 1945, 10.1093/rheumatology/kex260 Sohn, 2018, Late-onset systemic lupus erythematosus: is it "mild lupus"?, Lupus, 27, 235, 10.1177/0961203317716789 Norby, 2017, Outcome in biopsy-proven lupus nephritis: evaluation of biopsies from the Norwegian kidney biopsy registry, Lupus, 26, 881, 10.1177/0961203316686700 Tesar, 2015, Lupus nephritis: a different disease in European patients?, Kidney Dis, 1, 110, 10.1159/000438844 Jakes, 2012, Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality, Arthritis Care Res (Hoboken), 64, 159, 10.1002/acr.20683 Ahn, 2018, Prevalence, risk factors, and impact on mortality of neuropsychiatric lupus: a prospective, single-center study, Lupus, 27, 1338, 10.1177/0961203318772021 Kuo, 2015, Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected Families, JAMA Intern Med, 175, 1518, 10.1001/jamainternmed.2015.3528 Ulff-Moller, 2017, Family history of systemic lupus erythematosus and risk of autoimmune disease: nationwide Cohort Study in Denmark 1977–2013, Rheumatology (Oxford), 56, 957, 10.1093/rheumatology/kex005 Takvorian, 2014, Cigarette smoking, alcohol consumption and risk of systemic lupus erythematosus, Lupus, 23, 537, 10.1177/0961203313501400 Barbhaiya, 2018, Cigarette smoking and the risk of systemic lupus erythematosus, overall and by anti-double stranded DNA antibody subtype, in the Nurses' Health Study cohorts, Ann Rheum Dis, 77, 196, 10.1136/annrheumdis-2017-211675 Linn-Rasker, 2006, Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles, Ann Rheum Dis, 65, 366, 10.1136/ard.2005.041079 Harris, 2016, Endometriosis and the risks of systemic lupus erythematosus and rheumatoid arthritis in the Nurses' Health Study II, Ann Rheum Dis, 75, 1279, 10.1136/annrheumdis-2015-207704 Harris, 2016, Endometriosis and systemic lupus erythematosus: a population-based case-control study, Lupus, 25, 1045, 10.1177/0961203316631635 Barbhaiya, 2017, Influence of alcohol consumption on the risk of systemic lupus erythematosus among women in the nurses' health study cohorts, Arthritis Care Res (Hoboken), 69, 384, 10.1002/acr.22945 Parks, 2014, Pesticides, chemical and industrial exposures in relation to systemic lupus erythematosus, Lupus, 23, 527, 10.1177/0961203313511680 Young, 2017, Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus, Ann Rheum Dis, 76, 153, 10.1136/annrheumdis-2016-209157 Bernatsky, 2016, Fine particulate air pollution and systemic autoimmune rheumatic disease in two Canadian provinces, Environ Res, 146, 85, 10.1016/j.envres.2015.12.021 Fernandes, 2015, Exposure to air pollutants and disease activity in juvenile-onset systemic lupus erythematosus patients, Arthritis Care Res (Hoboken), 67, 1609, 10.1002/acr.22603 Tedeschi, 2017, Obesity and the risk of systemic lupus erythematosus among women in the Nurses' Health Studies, Semin Arthritis Rheum, 47, 376, 10.1016/j.semarthrit.2017.05.011 Mu, 2015, SLE: another autoimmune disorder influenced by microbes and diet?, Front Immunol, 6, 608, 10.3389/fimmu.2015.00608 Washio, 2014, Lifestyle and other related factors for the development of mixed connective tissue disease among Japanese females in comparison with systemic lupus erythematosus, Mod Rheumatol, 24, 788, 10.3109/14397595.2013.863442 Aparicio-Soto, 2017, An update on diet and nutritional factors in systemic lupus erythematosus management, Nutr Res Rev, 30, 118, 10.1017/S0954422417000026 Draborg, 2016, How compelling are the data for Epstein-Barr virus being a trigger for systemic lupus and other autoimmune diseases?, Curr Opin Rheumatol, 28, 398, 10.1097/BOR.0000000000000289 Parks, 2016, Early life factors associated with adult-onset systemic lupus erythematosus in women, Front Immunol, 7, 103, 10.3389/fimmu.2016.00103 Rojas-Villarraga, 2014, Safety of hormonal replacement therapy and oral contraceptives in systemic lupus erythematosus: a systematic review and meta-analysis, PLoS One, 9, 10.1371/journal.pone.0104303 Hevia, 2014, Intestinal dysbiosis associated with systemic lupus erythematosus, MBio, 5, 10.1128/mBio.01548-14 Lopez, 2016, Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients, Sci Rep, 6, 24072, 10.1038/srep24072 Mu, 2017, Control of lupus nephritis by changes of gut microbiota, Microbiome, 5, 73, 10.1186/s40168-017-0300-8 Manfredo Vieira, 2018, Translocation of a gut pathobiont drives autoimmunity in mice and humans, Science, 359, 1156, 10.1126/science.aar7201 Thanou, 2013, Top 10 things to know about lupus activity measures, Curr Rheumatol Rep, 15, 334, 10.1007/s11926-013-0334-2 Touma, 2018, A novel lupus activity index accounting for glucocorticoids: SLEDAI-2K glucocorticoid index, Rheumatology (Oxford), 57, 1370, 10.1093/rheumatology/key103 Isenberg, 2005, BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus, Rheumatology (Oxford), 44, 902, 10.1093/rheumatology/keh624 Mosca, 2011, Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice, Autoimmun Rev, 10, 383, 10.1016/j.autrev.2010.12.008 Wallace, 2009, A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus, Arthritis Rheum, 61, 1168, 10.1002/art.24699 Furie, 2009, Novel evidence-based systemic lupus erythematosus responder index, Arthritis Rheum, 61, 1143, 10.1002/art.24698 Manzi, 2012, Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials, Ann Rheum Dis, 71, 1833, 10.1136/annrheumdis-2011-200831 Furie, 2017, Anifrolumab, an anti-interferon-alpha receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus, Arthritis Rheum, 69, 376, 10.1002/art.39962 Furie, 2018, Systemic lupus erythematosus (SLE) responder index response is associated with global benefit for patients with SLE, Lupus, 27, 955, 10.1177/0961203318758506 Merrill, 2018, Efficacy and safety of atacicept in patients with systemic lupus erythematosus: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled, parallel-arm, phase IIb Study, Arthritis Rheum, 70, 266, 10.1002/art.40360 Wallace, 2014, Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study, Ann Rheum Dis, 73, 183, 10.1136/annrheumdis-2012-202760 Clowse, 2017, Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double-blind, placebo-controlled trials, Arthritis Rheum, 69, 362, 10.1002/art.39856 Thanou, 2014, Which outcome measures in SLE clinical trials best reflect medical judgment?, Lupus Sci Med, 1, 10.1136/lupus-2013-000005 Rovin, 2012, Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with Rituximab study, Arthritis Rheum, 64, 1215, 10.1002/art.34359 Furie, 2014, Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study, Arthritis Rheum, 66, 379, 10.1002/art.38260 Group, 2014, Treatment of lupus nephritis with abatacept: the abatacept and cyclophosphamide combination efficacy and safety study, Arthritis Rheum, 66, 3096, 10.1002/art.38790 Wofsy, 2012, Abatacept for lupus nephritis: alternative definitions of complete response support conflicting conclusions, Arthritis Rheum, 64, 3660, 10.1002/art.34624 Dall'Era, 2015, Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the euro-lupus nephritis cohort, Arthritis Rheum, 67, 1305, 10.1002/art.39026 Klein, 2011, Development of the CLASI as a tool to measure disease severity and responsiveness to therapy in cutaneous lupus erythematosus, Arch Dermatol, 147, 203, 10.1001/archdermatol.2010.435 Ruperto, 2011, International consensus for a definition of disease flare in lupus, Lupus, 20, 453, 10.1177/0961203310388445 Thanou, 2014, How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index, Rheumatology (Oxford), 53, 2175, 10.1093/rheumatology/keu153 Isenberg, 2011, An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA, Ann Rheum Dis, 70, 54, 10.1136/ard.2010.132068 Fanouriakis, 2018, Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: a real-life observational study, Semin Arthritis Rheum, 10.1016/j.semarthrit.2018.02.014 van Vollenhoven, 2017, A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS), Ann Rheum Dis, 76, 554, 10.1136/annrheumdis-2016-209519 Franklyn, 2016, Definition and initial validation of a lupus low disease activity state (LLDAS), Ann Rheum Dis, 75, 1615, 10.1136/annrheumdis-2015-207726 Zen, 2018, Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission, Ann Rheum Dis, 77, 104, 10.1136/annrheumdis-2017-211613 Ugarte-Gil, 2017, Remission and low disease activity status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL), Ann Rheum Dis, 76, 2071, 10.1136/annrheumdis-2017-211814 van Vollenhoven, 2012, Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response, Ann Rheum Dis, 71, 1343, 10.1136/annrheumdis-2011-200937 Roth, 2016, Elevated BLyS levels in patients with systemic lupus erythematosus: associated factors and responses to belimumab, Lupus, 25, 346, 10.1177/0961203315604909 Stohl, 2012, Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus, Arthritis Rheum, 64, 2328, 10.1002/art.34400 Md Yusof, 2017, Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus, Ann Rheum Dis, 76, 1829, 10.1136/annrheumdis-2017-211191 Vital, 2011, B cell biomarkers of rituximab responses in systemic lupus erythematosus, Arthritis Rheum, 63, 3038, 10.1002/art.30466 Wolf, 2016, Development of biomarker models to predict outcomes in lupus nephritis, Arthritis Rheum, 68, 1955, 10.1002/art.39623 Sutton, 2013, The systemic lupus international collaborating clinics (SLICC) damage index: a systematic literature review, Semin Arthritis Rheum, 43, 352, 10.1016/j.semarthrit.2013.05.003 Bruce, 2015, Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the systemic lupus international collaborating clinics (SLICC) inception cohort, Ann Rheum Dis, 74, 1706, 10.1136/annrheumdis-2013-205171 Costenbader, 2010, Development and initial validation of a self-assessed lupus organ damage instrument, Arthritis Care Res (Hoboken), 62, 559, 10.1002/acr.20193 Yazdany, 2011, Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus, Arthritis Care Res (Hoboken), 63, 1170, 10.1002/acr.20503 Yurkovich, 2014, Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies, Arthritis Care Res (Hoboken), 66, 608, 10.1002/acr.22173 Thomas, 2014, Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis, Arthritis Rheum, 66, 2503, 10.1002/art.38731 Avina-Zubieta, 2017, Risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: a general population-based study, Arthritis Care Res (Hoboken), 69, 849, 10.1002/acr.23018 Arkema, 2017, Stroke in systemic lupus erythematosus: a Swedish population-based cohort study, Ann Rheum Dis, 76, 1544, 10.1136/annrheumdis-2016-210973 Bernatsky, 2013, Cancer risk in systemic lupus: an updated international multi-centre cohort study, J Autoimmun, 42, 130, 10.1016/j.jaut.2012.12.009 Wadstrom, 2017, Cervical neoplasia in systemic lupus erythematosus: a nationwide study, Rheumatology (Oxford), 56, 613 Tektonidou, 2015, Burden of serious infections in adults with systemic lupus erythematosus: a national population-based study, 1996-2011, Arthritis Care Res (Hoboken), 67, 1078, 10.1002/acr.22575 Mahieu, 2016, Patient-reported outcomes in systemic lupus erythematosus, Rheum Dis Clin N Am, 42, 253, 10.1016/j.rdc.2016.01.001 Jorge, 2018, Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999–2014), Rheumatology (Oxford), 57, 337, 10.1093/rheumatology/kex412 Tektonidou, 2017, Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016, Ann Rheum Dis, 76, 2009, 10.1136/annrheumdis-2017-211663 Gomez-Puerta, 2015, Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox, Arthritis Rheum, 67, 752, 10.1002/art.38981 Furst, 2013, Incidence and prevalence of adult systemic lupus erythematosus in a large US managed-care population, Lupus, 22, 99, 10.1177/0961203312463110 Ingvarsson, 2016, Variations in the epidemiology of systemic lupus erythematosus in southern Sweden, Lupus, 25, 772, 10.1177/0961203316635288 Lerang, 2012, High incidence and prevalence of systemic lupus erythematosus in Norway, Lupus, 21, 1362, 10.1177/0961203312458168 Fatoye, 2018, Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada, Rheumatol Int, 10.1007/s00296-018-4091-4 Liang, 1989, Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus, Arthritis Rheum, 32, 1107, 10.1002/anr.1780320909 Vitali, 1992, Clin Exp Rheumatol, 10, 541 Bombardier, 1992, Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE, Arthritis Rheum, 35, 630, 10.1002/art.1780350606 Gladman, 2002, Systemic lupus erythematosus disease activity index 2000, J Rheumatol, 29, 288 Buyon, 2005, The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial, Ann Intern Med, 142, 953, 10.7326/0003-4819-142-12_Part_1-200506210-00004 Symmons, 1988, Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG), Q J Med, 69, 927